Relapsing-remitting multiple scleroris and the role of vitamin D: An agent based model

ACM BCB 2014 - 5th ACM Conference on Bioinformatics, Computational Biology, and Health Informatics

Volumn , Issue , 2014, Pages 744-748

  Pappalardo, Francesco ^a   Pennisi, Marzio ^a   Rajput, Abdul Mateen ^b   Chiacchio, Ferdinando ^a   Motta, Santo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Rheinische Friedrich Wilhelms Universität   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMOUS AGENTS; BIOINFORMATICS; MEDICAL INFORMATICS; SIMULATION PLATFORM; VITAMINS;

AGENT-BASED MODEL; COMPUTATIONAL MODEL; EXTERNAL FACTORS; IMMUNE MECHANISM; IMMUNOMODULATORY; MULTIPLE SCLEROSIS; TEST AND VERIFY; VITAMIN-D;

COMPUTATIONAL METHODS;

EID: 84920736202     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1145/2649387.2660844     Document Type: Conference Paper

References (36)

1. A. Ascherio, K. Munger, E. Lennette, D. Spiegelman, M. Hernán, M. Olek, S. Hankinson, and D. Hunter. Epstein-barr virus antibodies and risk of multiple sclerosis: A prospective study. JAMA, 286(24):3083-3088, Dec 2001.
2. F. Barrat, D. Cua, A. Boonstra, D. Richards, C. Crain, H. Savelkoul, R. de Waal-Malefyt, R. Coffman, C. Hawrylowicz, and A. O'Garra. In vitro generation of interleukin 10-producing regulatory cd4(+) t cells is induced by immunosuppressive drugs and inhibited by t helper type 1 (th1)- And th2-inducing cytokines. J Exp Med, 195(5):603-613, Mar 2002.
3. B. Becklund, K. Severson, S. Vang, and H. De Luca. Uv radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin d production. Proc Natl Acad Sci USA, 107:6418-6423, 2010.
4. A. Bhalla, E. Amento, and B. S. L. Glimcher. 1, 25-dihydroxyvitamin d3 inhibits antigen-induced t cell activation. J Immunol, 133(4):1748-1754, Oct 1984.
5. A. Boiko, G. Vorobeychik, D. Paty, V. Devonshire, D. Sadovnick, and U. of British Columbia MS Clinic Neurologists". Early onset multiple sclerosis: A longitudinal study. Neurology, 59(7):1006-1010, Oct 2002.
6. J. Carneiro, K. Leon, I. Caramalho, C. van den Dool, R. Gardner, V. Oliveira, M. Bergman, N. Sepúlveda, T. Paixão, J. Faro, and J. Demengeot. When three is not a crowd: A crossregulation model of the dynamics and repertoire selection of regulatory cd4+ t cells. Immunol Rev, 216:48-68, Apr 2007.
7. N. de Mendizabal, J. Carneiro, R. Sole, J. Goni, J. Bragard, I. Martinez-Forero, S. Martinez-Pasamar, J. Sepulcre, J. Torrealdea, F. Bagnato, J. Garcia-Ojalvo, and P. Villoslada. Modeling the effector - regulatory t cell cross-regulation reveals the intrinsic character of relapses in multiple sclerosis. BMC Systems Biology, 5:114 doi:10.1186/1752-0509-5-114, 2010.
8. N. V. deMendizábal, J. Carneiro, R. Solé, J. Goñi, J. Bragard, I. M.-F. S. Martinez-Pasamar, J. Sepulcre, J. Torrealdea, F. Bagnato, J. Garcia-Ojalvo, and P. Villoslada. Modeling the effector - regulatory t cell cross-regulation reveals the intrinsic character of relapses in multiple sclerosis. BMC Syst Biol, 5(114), Jul 15 2011.
9. J. Dörr, A. Döring, and F. Paul. Can we prevent or treat multiple sclerosis by individualised vitamin d supply? EPMA Journal, 4(4):1-12, 2013.
10. J. Fontenot and A. Rudensky. A well adapted regulatory contrivance: regulatory t cell development and the forkhead family transcription factor foxp3. Nat Immunol, 6(4):331-337, Apr 2005.
11. D. Godin. The causal cascade to multiple sclerosis: A model for ms pathogenesis. PLoS One, 4(2):e4565, Feb 2009.
12. S. Gorman, L. Kuritzky, M. Judge, K. Dixon, J. McGlade, R. Mason, J. Finlay-Jones, and P. Hart. Topically applied 1, 25-dihydroxyvitamin d3 enhances the suppressive activity of cd4+cd25+ cells in the draining lymph nodes. J Immunol, 179(9):6273-6283, Nov 2007.
13. S. Gregori, M. Casorati, S. Amuchastegui, S. Smiroldo, A. Davalli, and L. Adorini. Regulatory t cells induced by 1 alpha, 25-dihydroxyvitamin d3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol, 167(4):1945-1953, Aug 2001.
14. S. jr Simpson, B. Taylor, L. Blizzard, A. Ponsonby, F. Pittas, H. Tremlett, T. Dwyer, P. Gies, and I. V. der Mei. Higher 25-hydroxyvitamin d is associated with lower relapse risk in multiple sclerosis. Ann Neurol, 68:193-203, 2010.
15. M. Kremenchutzky, G. Rice, J. Baskerville, D. Wingerchuk, and G. Ebers. The natural history of multiple sclerosis: A geographically based study 9: observations on the progressive phase of the disease. Brain, 129(Pt 3):584-594, Mar 2006.
16. J. Lemire and D. Archer. 1, 25-dihydroxyvitamin d3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest, 87:1103-1107, 1991.
17. J. Lund, L. Hsing, T. Pham, and A. Rudensky. Coordination of early protective immunity to viral infection by regulatory t cells. Science, 320(5880):1220-1224, May 2008.
18. F. Mirzaei, K. Michels, K. Munger, E. O'Reilly, T. Chitnis, M. Forman, E. Giovannucci, B. Rosner, and A. Ascherio. Gestational vitamin d and the risk of multiple sclerosis in offspring. Ann Neurol, 70:30-40, 2011.
19. K. Munger, L. Levin, B. Hollis, N. Howard, and A. Ascherio. Serum 25- hydroxyvitamin d levels and risk of multiple sclerosis. JAMA, 296:2832-2838, 2006.
20. K. Munger, S. Zhang, E. O'Reilly, M. Hernán, M. Olek, W. Willett, and A. Ascherio. Vitamin d intake and incidence of multiple sclerosis. Neurology, 62:60-65, 2004.
21. Moilu Hänninen, L. Airas, I. Mononen, A. Heikkilä, M. Viljanen, and A. Hänninen. 25-hydroxyvitamin d levels in serum at the onset of multiple sclerosis. Mult Scler, 11:266-271, 2005.
22. F. Pappalardo, E. Mastriani, P. Lollini, and S. Motta. Agent based modeling of lung metastasis-immune system competition. Lecture Notes in Computer Science, 3849:223-228, 2006.
23. L. Pedersen, F. Nashold, K. Spach, and C. Hayes. 1, 25-dihydroxyvitamin d3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res, 85:2480-2490, 2007.
24. G. Penna, A. Roncari, S. Amuchastegui, K. Daniel, E. Berti, M. Colonna, and L. Adorini. Expression of the inhibitory receptor ilt3 on dendritic cells is dispensable for induction of cd4+foxp3+ regulatory t cells by 1, 25-dihydroxyvitamin d3. Blood, 106(10):3490-3497, Nov 2005.
25. M. Pennisi, F. Pappalardo, and S. Motta. Agent based modeling of lung metastasis-immune system competition. Lecture Notes in Computer Science, 5666:1-3, 2009.
26. M. Pennisi, A. Rajput, L. Toldo, and F. Pappalardo. Agent based modeling of treg-teff cross regulation in relapsing-remitting multiple sclerosis. BMC Bioinformatics, 14((Suppl 16)):S9, 2013.
27. A. Ponsonby, I. van der Mei, T. Dwyer, L. Blizzard, B. Taylor, A. Kemp, R. Simmons, and T. Kilpatrick. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA, 293(4):463-469, Jan 2005.
28. S. Ramagopalan, N. Maugeri, L. Handunnetthi, M. Lincoln, S.-M. Orton, D. Dyment, G. De Luca, B. Herrera, M. Chao, A. Sadovnick, and G. Ebers. Expression of the multiple sclerosis-associated mhc class ii allele hla-drb1∗1501 is regulated by vitamin d. PLoS Genetics, 5(2):e1000369. doi:10.1371/journal.pgen.1000369, 2009.
29. G. Rosati. The prevalence of multiple sclerosis in the world: An update. Neurol Sci, 22(2):117-139, Apr 2001.
30. T. Runia, W. Hop, Y. D. Rijke, D. Buljevac, and R. Hintzen. Relationship between 25-oh-d serum level and relapse rate in multiple sclerosis patients before and after vitamin d supplementation. Neurology, 79:261-266, 2012.
31. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. Immunologic self-tolerance maintained by activated t cells expressing il-2 receptor alpha-chains (cd25). breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 155(3):1151-1164, Aug 1995.
32. M. Sospedra and R. Martin. Immunology of multiple sclerosis. Annu Rev Immunol, 33:683-747, 2005.
33. L. Steinman. Multiple sclerosis: A two-stage disease. Nat Immunol, 2(9):762-764, Sep 2001.
34. P. Sundström, P. Juto, G. Wadell, G. Hallmans, A Svenningsson, L. Nyström, J. Dillner, and L. Forsgren. An altered immune response to epstein-barr virus in multiple sclerosis a prospective study. Neurology, 62:2277-2282, 2004.
35. B. Trapp, R. Ransohoff, and R. Rudick. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol, 12(3):295-302, Jun 1999.
36. U. Wilensky. Netlogo. Technical report, Center for Connected Learning and Computer-Based Modeling, Northwestern University, Evanston, IL., 1999.